Martin Schmieg has resigned as senior vice president and CFO of Sirna Therapeutics for personal and family reasons, effective April 22, the
Michael Venuti has become chief scientific officer of Discovery Partners International, the San Diego-based company said today. He has been a member of Discovery's board of directors since 2003. Venuti joins Discovery from Celera Genomics, where he was senior vice president. He holds a PhD in organic chemistry from the Massachusetts Institute of Technology and an AB in chemistry from
Mike Evans will become chief executive officer of Oxford Gene Technology in three months, according to the company. He has also been named director of technical affairs and resource management. He previously held senior administrative positions at Amersham Biosciences and Ascot Fine Chemicals. Evans holds a DPhil, an MA, and a BA in biochemistry from Oxford University.
Sydney Brenner has received the 2005 UCSD/Merck Life Sciences Achievement Award, the
Paul Smith has become vice president of North American and European sales of Ciphergen, the company said on Monday. His appointment is part of the "broad restructuring" of Ciphergen's sales effort.
Andrew Chu has become director of business development, and Ian Mehr has been promoted to vice president of business development of Qualyst, the Research Triangle Park, NC-based ADMET company said on Monday. Most recently,
Gerald Wagner has joined the board of directors of IntregaGen, the Paris-based personalized medicine company said today. During his career, he held senior positions at Agfa and Bayer, retiring from Bayer in 2002. Wagner holds a PhD from the Technical University Darmstadt in
Gary Carter has become vice president of corporate development of CeMines, the Golden, Colo.-based company said yesterday. Most recently, he was responsible for market research at Transgenomic. Prior to that, he was manager of market research at Proligo. Earlier, he held various executive positions at Genomica. Carter holds a master's degree in marketing research from the
Richmond Wolf has become chairman of the advisory board of Arrowhead Research, the company said last week. He is the director of the office of technology transfer at the California Institute of Technology. Wolf received a PhD from Caltech and an undergraduate degree from
Eran Aharonson has become vice president for computational life science research and development of Compugen, the Tel Aviv-based company said on Monday. He joins Compugen from Advanced Recognition Technologies, where he was chief executive officer. Aharonson holds master's and bachelor's degrees in computer science from the Israel Institute of Technology.
Philippe Bogard has become strategic marketing manager of Nonlinear Dynamics, the
Robert Shapiro has joined the board of directors of Dyadic as an independent director, the Jupiter, Fla.-based company said last week. He is the former chairman and chief executive officer of Monsanto and chairman of Pharmacia. Shapiro holds a JD from Columbia University School of Law and a bachelor's degree from
Staf Van Reet has been appointed as vice president of corporate development of Galapagos, the
Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.